The Effect of Levofloxacin Combinations on CRP Decrease in SARS CoV-2 Pneumonia
Abstract
Objective: Covid 19 pneumonia, caused by the SARS-CoV-2 virus, is a disease with severe damage to the lung. It was reported that in Covid 19, rate of 74% antibiotics were used, and secondary bacterial infections were detected in at least 17.6% of the patients who used antibiotics. In this study, the effects of antibiotics in Covid 19 patients who do not use the steroid on CRP decrease were aimed.
Materials and Methods: It was done in Ersin Arslan Training and Research Hospital Covid Wards between January 1, 2020, and December 31, 2020. The study included with positive PCR test (SARS-CoV-2), 18 age and more than, with pneumonia in CT, but users of steroid were excluded. Ages, genders, comorbidities, WBC values, neutrophil values, CRP values (in the first 24 hours and the 3rd day), lung involvements in CT and antibiotics of the patients were analyzed retrospectively. Accordingly, a total of 202 patients who compatible criteria were included in the study. Chi Square Test was used in the statistical analysis of the data.
Results: The mean age was 60.2±2.57 (19-89). 53.9% of the patients were males and 46.1% females. There was a history of chronic disease in 54.9% of the patients. Findings of pneumonia in CT were 67.8% multifocal, and 32.2% unifocal. Covid 19 pneumonia was more often in males, in over 60 ages and in have a history of chronic disease. Antibiotics used were levofloxacin (L) and combined levofloxacin with piperacillin/tazobactam (LT) and meropenem (LM) and…
Read the paper
Related studies
- Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Association between cord blood 25-hydroxyvitamin D concentrations and respiratory tract infections in the first 6 months of age in a Korean population: a birth cohort study (COCOA)
- GC-MS Analysis and Biomedical Therapy of Oil from n-Hexane Fraction of Scutellaria edelbergii Rech. f.: In Vitro, In Vivo, and In Silico Approach
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.